Home » Topics » BioWorld Science, Immune

BioWorld Science, Immune
RSS

HitGen presents new IL-17RA antagonists

Dec. 9, 2019

Xenikos initiates phase III study of T-Guard for steroid-refractory GvHD

Dec. 4, 2019

Vi-DT typhoid conjugate vaccine begins phase III study in Nepal

Dec. 2, 2019

"Membrane-anchored molecular adjuvant" improves rabies vaccine

Nov. 29, 2019

Prokarium receives MHRA clearance to begin first-in-human study of enteric fever vaccine Entervax

Nov. 28, 2019

Malaria discovery may lead to better HIV and lupus treatments

Nov. 26, 2019

U.K. clearance for phase I/II study of TX-200 in kidney transplantation

Nov. 19, 2019

Bristol-Myers Squibb divulges TLR7 agonists

Nov. 19, 2019

Double-duty CD4+ T cells may hold key to longevity

Nov. 19, 2019

New PEGylated IL-2 with improved pharmacologic properties specifically activates and expands Tregs

Nov. 18, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...